Pharma Imaging Network for Therapeutics and Diagnostics (PINTAD): Difference between revisions
Jump to navigation
Jump to search
| Line 2: | Line 2: | ||
*[[Media:PINTAD Meeting Minutes 31MAY13.pdf|31May2013 PINTAD Meeting Minutes]] | *[[Media:PINTAD Meeting Minutes 31MAY13.pdf|31May2013 PINTAD Meeting Minutes]] | ||
**[[Media:Raunig SCT 2013 Presentation V2-21MAY2013.pdf|Supplemental material: Dr. Raunig's SCT 2013 Presentation (21 May 2013)]] | |||
*[[Media:PINTAD Meeting Minutes 26APR13.pdf|26Apr2013 PIG Meeting Minutes]] | *[[Media:PINTAD Meeting Minutes 26APR13.pdf|26Apr2013 PIG Meeting Minutes]] | ||
**[[Media:EMA Dec2012.pdf|Supplemental material: European Medicines Agency, Science Medicines Health, Appendix 1 to the guideline on the evaluation of anticancer medicinal products in man (13 December 2012)]] | **[[Media:EMA Dec2012.pdf|Supplemental material: European Medicines Agency, Science Medicines Health, Appendix 1 to the guideline on the evaluation of anticancer medicinal products in man (13 December 2012)]] | ||